Your browser doesn't support javascript.
loading
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study.
Monti, Manuela; Degenhardt, Tom; Brain, Etienne; Wuerstlein, Rachel; Argusti, Alessandra; Puntoni, Matteo; Rollandi, Gian Andrea; Corradengo, Davide; Boni, Luca; Ilhan, Harun; Nanni, Oriana; Cortes, Javier; Piris-Gimenez, Alejandro; Piccardo, Arnoldo; Iacozzi, Massimiliano; Matteucci, Federica; Di Iorio, Valentina; Alberini, Jean Louis; Schröder, Carolien; Harbeck, Nadia; Gennari, Alessandra.
Afiliação
  • Monti M; Unit of Biostatistics and Clinical Trials, Istituto di Ricovero e Cura a Carattere Scienteifico Istituto Romagnolo per lo Studio dei Tumori "DinoAmadori", Meldola, Italy.
  • Degenhardt T; Breast Center, Department of Obstetrics and Gynaecology, Ludwig Maximilians University Hospital of Munich, Munich, Germany.
  • Brain E; Department of Clinical Research and Medical Oncology, Institut Curie-Hopital "René Huguenin", Saint-Cloud, France.
  • Wuerstlein R; Breast Center, Department of Obstetrics and Gynaecology, Ludwig Maximilians University Hospital of Munich, Munich, Germany.
  • Argusti A; Clinical Trial Research Unit, Ente Ospedaliero Galliera Hospital, Genoa, Italy.
  • Puntoni M; Clinical Trial Research Unit, Ente Ospedaliero Galliera Hospital, Genoa, Italy.
  • Rollandi GA; Clinical Trial Research Unit, Ente Ospedaliero Galliera Hospital, Genoa, Italy.
  • Corradengo D; Clinical Trial Research Unit, Ente Ospedaliero Galliera Hospital, Genoa, Italy.
  • Boni L; Clinical Trials Unit, Istituto Nazionale per la Ricerca sul Cancro Istituto Scientifico Tumori, Genoa, Italy.
  • Ilhan H; Die Radiologie (Centre for Radiology, Nuclear Medicine and Radiotherapy), Munich, Germany.
  • Nanni O; Unit of Biostatistics and Clinical Trials, Istituto di Ricovero e Cura a Carattere Scienteifico Istituto Romagnolo per lo Studio dei Tumori "DinoAmadori", Meldola, Italy.
  • Cortes J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Piris-Gimenez A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Piccardo A; Department of Nuclear Medicine, Ente Ospedaliero Galliera Hospitals, Genoa, Italy.
  • Iacozzi M; Department of Nuclear Medicine, Ente Ospedaliero Galliera Hospitals, Genoa, Italy.
  • Matteucci F; Unit of Biostatistics and Clinical Trials, Istituto di Ricovero e Cura a Carattere Scienteifico Istituto Romagnolo per lo Studio dei Tumori "DinoAmadori", Meldola, Italy.
  • Di Iorio V; Unit of Biostatistics and Clinical Trials, Istituto di Ricovero e Cura a Carattere Scienteifico Istituto Romagnolo per lo Studio dei Tumori "DinoAmadori", Meldola, Italy.
  • Alberini JL; Nuclear Medicine Department, Centre "Georges-François Leclerc", Dijon, France.
  • Schröder C; Department of Medical Oncology, Dutch Cancer Institute Nederlands Kanker Instituut - Antoni Van Leeuwenhoek, Amsterdam, Netherlands.
  • Harbeck N; Breast Center, Department of Obstetrics and Gynaecology, Ludwig Maximilians University Hospital of Munich, Munich, Germany.
  • Gennari A; Department of Translational Oncology, University of Eastern Piedmont, Novara, Italy.
Front Med (Lausanne) ; 8: 817678, 2021.
Article em En | MEDLINE | ID: mdl-35096909
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article